Streptomyces bacteria have a remarkable capacity to biosynthesize natural products. The discovery of streptothricin in 1942 led to a wave of Streptomyces pharmaceutical research. Though reisolation and declining structural novelty eventually led to an industrial exit, decreases in the cost of genomic sequencing have reinvigorated microbial natural products. The expansion of genetic data has shown that bacteria have a genetic biosynthetic capacity larger than has been reported chemically. Biosynthetic genes often form Biosynthetic Gene Clusters (BGCs) within bacterial genomes allowing bioinformatic-based biosynthetic predictions. Despite this, efforts to classify identified BGCs have shown that most relate to unknown chemistry. However, rece...
Bacteria are the source of many important medicines, including antibiotics, anticancer, anti-inflamm...
<div><p><i>Streptomyces</i> spp. are robust producers of medicinally-, industrially- and agricultura...
BackgroundConsiderable advances have been made in our understanding of the molecular genetics of sec...
The presence of secondary metabolite biosynthetic gene clusters (BGCs) makes actinobacteria well-kno...
Natural products from microbes have provided humans with beneficial antibiotics for millennia. Howev...
International audienceSpecialized metabolites are of great interest due to their possible industrial...
Streptomyces are Gram-positive bacteria of significant industrial importance due to their ability to...
Antibiotic development based on natural products has faced a long lasting decline since the 1970s, w...
Actinobacteria encode a wealth of natural product biosynthetic gene clusters (NPGCs), whose systemat...
International audienceSince the discovery of the streptomycin produced by Streptomyces griseus in th...
Streptomyces are a group of Gram-positive bacteria belonging to the Actinobacteria class, which are ...
Bacterial secondary metabolites have been studied for decades for their usefulness as drugs, such as...
Secondary metabolites are produced by many microbes. They are not essential for life, but may provid...
Bacteria are the source of many important medicines, including antibiotics, anticancer, anti-inflamm...
<div><p><i>Streptomyces</i> spp. are robust producers of medicinally-, industrially- and agricultura...
BackgroundConsiderable advances have been made in our understanding of the molecular genetics of sec...
The presence of secondary metabolite biosynthetic gene clusters (BGCs) makes actinobacteria well-kno...
Natural products from microbes have provided humans with beneficial antibiotics for millennia. Howev...
International audienceSpecialized metabolites are of great interest due to their possible industrial...
Streptomyces are Gram-positive bacteria of significant industrial importance due to their ability to...
Antibiotic development based on natural products has faced a long lasting decline since the 1970s, w...
Actinobacteria encode a wealth of natural product biosynthetic gene clusters (NPGCs), whose systemat...
International audienceSince the discovery of the streptomycin produced by Streptomyces griseus in th...
Streptomyces are a group of Gram-positive bacteria belonging to the Actinobacteria class, which are ...
Bacterial secondary metabolites have been studied for decades for their usefulness as drugs, such as...
Secondary metabolites are produced by many microbes. They are not essential for life, but may provid...
Bacteria are the source of many important medicines, including antibiotics, anticancer, anti-inflamm...
<div><p><i>Streptomyces</i> spp. are robust producers of medicinally-, industrially- and agricultura...
BackgroundConsiderable advances have been made in our understanding of the molecular genetics of sec...